Andrew Paterson

Andrew Paterson is a deeply experienced R&D leader and entrepreneur in the medical diagnostics field, with a strong foundation in chemical and biomolecular engineering. He co-founded Luminostics, later rebranded as Clip Health, to commercialize a smartphone-based diagnostic platform utilizing persistent luminescent phosphors for highly sensitive point-of-care testing. His work in this area has been recognized with a Young Investigator Award and has resulted in numerous publications and patents. theorg+3

His expertise includes diagnostics, nanoparticles, bioconjugation, persistent luminescence, and phosphors, as evidenced by his extensive academic contributions and patent activity. He has specifically focused on developing innovative solutions for rapid and sensitive detection of biomarkers, including early work on hCG and later applications for infectious diseases like dengue fever and chlamydia. google+3

Andrew has a demonstrated ability to translate cutting-edge academic research into commercial applications, participating in Y Combinator and successfully leading R&D efforts at both Luminostics and Clip Health. His current roles at bioMérieux as Associate Director, R&D Chemistry and Innovation Leader (Microbiology) further highlight his continued leadership in advanced diagnostic and life science technologies. theorg+1